Inspection Delay Puts Back Hanmi/Spectrum’s Rolontis

US Action Date Now Set For Feb '21

ReviewStamp_1200x675
FDA Unable To Visit Hanmi’s Bioplant On Travel Restrictions • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia